Asia Pacific Home Infusion Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product (Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors), Application (Anti-Infective, Endocrinology, Enteral Nutrition, Hydration Therapy, Chemotherapy, Specialty Pharmaceuticals, and Others), and Route of Administration (Intramuscular, Subcutaneously, and Epidural)
The Asia Pacific home infusion therapy market is expected to grow from US$ 3,340.35 million in 2022 to US$ 5,725.65 million by 2028. It is estimated to grow at a CAGR of 9.4% from 2022 to 2028.
Increasing Healthcare Potential of Developing Economies and Rising Prevalence of Healthcare-Associated
Infections is Driving Asia Pacific Home Infusion Therapy Market
Developing countries report a high prevalence of chronic diseases due to significant shifts in people’s lifestyles. Leading pharmaceutical companies have been focusing on increasing their reach across emerging markets by expanding their distribution networks and augmented manufacturing capabilities.
In developing countries, the number of patients receiving home infusion therapy has been limited in the past. Even though hospitals have rapidly adopted smart infusion pumps integrated with features such as electronic health records (EHR) integration and medication safety software, the majority of home infusion service providers continue to use traditional pumps. However, developing countries are focused on improving their healthcare infrastructure and services, which is encouraging the healthcare sector to upgrade these products and services. Moreover, significant investments in research and development play a key role in the technological upgrade of products and services in emerging countries. With the increasing availability of such upgraded medical offerings, their use is likely to rise in these countries in the future.
Due to the COVID-19 pandemic, hospitals were under huge pressure to cater to a vast number of patients, which resulted in overpopulated emergency rooms (ERs), and overwhelmed doctors and medical staff; therefore, the healthcare sectors in developing countries witnessed a crucial shift to homecare settings. Additionally, many patients withdrew from treatments within hospital settings due to the fear of contracting COVID-19, making home care a good option. In addition, patients were prone to hospital-acquired infections or healthcare-associated infections (HAIs) while receiving services in hospitals or other healthcare facilities. With high morbidity and mortality rates, HAIs cost healthcare systems billions of dollars annually. With growing infection rates, there is an increased focus on reducing the incidence of HAIs, owing to the huge costs associated with treating these infections that exert additional economic burdens on the healthcare system. Thus, due to COVID-19 pandemic, home infusion is perceived as an effective treatment option to reduce the risk of getting the HAIs, which serves as a significant opportunity for the home infusion therapy market.
Asia Pacific Home Infusion Therapy Market Overview
The Asia Pacific home infusion therapy market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2021, and India is expected to register a significant CAGR in the market. The market growth in these countries is attributed to the increasing prevalence of chronic diseases, the rising geriatric population, the growing presence of home infusion therapy providers, and the rising number of government initiatives. The Chinese government has adopted Healthy China 2030 to facilitate healthcare services within the nation while delivering great benefits worldwide. The population in the country is more prone to infectious, chronic, and acute diseases. China faces a high burden of lung cancer, colorectal cancer, esophageal cancer, heart disease, and diabetes. Further, the growing presence of local key players is boosting the growth of the home infusion therapy market in China. Manufacturers are focusing on expanding their strategic global presence and specialized expertise with exclusive technological capabilities, leading to the expansion of the home infusion therapy market in China. Hence, the rise in the prevalence of diabetes and chronic diseases, the increase in the geriatric population, and the surge in the number of regional players are expected to propel the growth of the home infusion therapy market in China during the forecast period.
Asia Pacific Home Infusion Therapy Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Home Infusion Therapy Market Segmentation
The Asia Pacific home infusion therapy market is segmented into product, application, route of administration and country.
Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The home infusion therapy market segment is sub segmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2022.
Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2022.
Based on route of administration, the home infusion therapy market is segmented into intramuscular, subcutaneously, and epidural. The intramuscular segment held the largest share of the market in 2022.
Based on country, the Asia Pacific home infusion therapy market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.
B. Braun Melsungen AG; Baxter International Inc; Nipro Corp; Becton Dickinson and Co; Fresenius Kabi AG; ICU Medical Inc; JMS Co Ltd; Terumo Corp are the leading companies operating in the Asia Pacific home infusion therapy market.
Increasing Healthcare Potential of Developing Economies and Rising Prevalence of Healthcare-Associated
Infections is Driving Asia Pacific Home Infusion Therapy Market
Developing countries report a high prevalence of chronic diseases due to significant shifts in people’s lifestyles. Leading pharmaceutical companies have been focusing on increasing their reach across emerging markets by expanding their distribution networks and augmented manufacturing capabilities.
In developing countries, the number of patients receiving home infusion therapy has been limited in the past. Even though hospitals have rapidly adopted smart infusion pumps integrated with features such as electronic health records (EHR) integration and medication safety software, the majority of home infusion service providers continue to use traditional pumps. However, developing countries are focused on improving their healthcare infrastructure and services, which is encouraging the healthcare sector to upgrade these products and services. Moreover, significant investments in research and development play a key role in the technological upgrade of products and services in emerging countries. With the increasing availability of such upgraded medical offerings, their use is likely to rise in these countries in the future.
Due to the COVID-19 pandemic, hospitals were under huge pressure to cater to a vast number of patients, which resulted in overpopulated emergency rooms (ERs), and overwhelmed doctors and medical staff; therefore, the healthcare sectors in developing countries witnessed a crucial shift to homecare settings. Additionally, many patients withdrew from treatments within hospital settings due to the fear of contracting COVID-19, making home care a good option. In addition, patients were prone to hospital-acquired infections or healthcare-associated infections (HAIs) while receiving services in hospitals or other healthcare facilities. With high morbidity and mortality rates, HAIs cost healthcare systems billions of dollars annually. With growing infection rates, there is an increased focus on reducing the incidence of HAIs, owing to the huge costs associated with treating these infections that exert additional economic burdens on the healthcare system. Thus, due to COVID-19 pandemic, home infusion is perceived as an effective treatment option to reduce the risk of getting the HAIs, which serves as a significant opportunity for the home infusion therapy market.
Asia Pacific Home Infusion Therapy Market Overview
The Asia Pacific home infusion therapy market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2021, and India is expected to register a significant CAGR in the market. The market growth in these countries is attributed to the increasing prevalence of chronic diseases, the rising geriatric population, the growing presence of home infusion therapy providers, and the rising number of government initiatives. The Chinese government has adopted Healthy China 2030 to facilitate healthcare services within the nation while delivering great benefits worldwide. The population in the country is more prone to infectious, chronic, and acute diseases. China faces a high burden of lung cancer, colorectal cancer, esophageal cancer, heart disease, and diabetes. Further, the growing presence of local key players is boosting the growth of the home infusion therapy market in China. Manufacturers are focusing on expanding their strategic global presence and specialized expertise with exclusive technological capabilities, leading to the expansion of the home infusion therapy market in China. Hence, the rise in the prevalence of diabetes and chronic diseases, the increase in the geriatric population, and the surge in the number of regional players are expected to propel the growth of the home infusion therapy market in China during the forecast period.
Asia Pacific Home Infusion Therapy Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Home Infusion Therapy Market Segmentation
The Asia Pacific home infusion therapy market is segmented into product, application, route of administration and country.
Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The home infusion therapy market segment is sub segmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2022.
Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2022.
Based on route of administration, the home infusion therapy market is segmented into intramuscular, subcutaneously, and epidural. The intramuscular segment held the largest share of the market in 2022.
Based on country, the Asia Pacific home infusion therapy market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.
B. Braun Melsungen AG; Baxter International Inc; Nipro Corp; Becton Dickinson and Co; Fresenius Kabi AG; ICU Medical Inc; JMS Co Ltd; Terumo Corp are the leading companies operating in the Asia Pacific home infusion therapy market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Home Infusion Therapy Market – by Product
1.3.2 Asia Pacific Home Infusion Therapy Market – by Application
1.3.3 Asia Pacific Home Infusion Therapy Market – by Route of Administration
1.3.4 Asia Pacific Home Infusion Therapy Market – by Country
2. ASIA PACIFIC HOME INFUSION THERAPY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC HOME INFUSION THERAPY MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.2.1 Expert’s Opinion
5. ASIA PACIFIC HOME INFUSION THERAPY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Incidences of Chronic Disorders Coupled with Rising Geriatric Population
5.1.2 Reduction in Duration of Hospital Stays and Cost of Care
5.2 Market Restraints
5.2.1 Recalls of Infusion Pumps and Safety Concerns Associated with Home Infusion
5.3 Market Opportunities
5.3.1 Increasing Healthcare Potential of Developing Economies and Rising Prevalence of Healthcare-Associated Infections
5.4 Future Trends
5.4.1 Addressing Unmet Needs of Patients Suffering from Oncological and Hematological Conditions
5.5 Impact Analysis
6. HOME INFUSION THERAPY MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7. ASIA PACIFIC HOME INFUSION THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT
7.1 Overview
7.2 Asia Pacific Home Infusion Therapy Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Infusion Pumps
7.3.1 Overview
7.3.2 Infusion Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Insulin Pumps
7.3.3.1 Overview
7.3.3.2 Insulin Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Elastomeric Pumps
7.3.4.1 Overview
7.3.4.2 Elastomeric Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Syringe Pumps
7.3.5.1 Overview
7.3.5.2 Syringe Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intravenous Sets
7.4.1 Overview
7.4.2 Intravenous Sets: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 IV Cannulas
7.5.1 Overview
7.5.2 IV Cannulas: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Needleless Connectors
7.6.1 Overview
7.6.2 Needleless Connectors: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC HOME INFUSION THERAPY MARKET ANALYSIS AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 Asia Pacific Home Infusion Therapy Market, by Application 2021 & 2028 (%)
8.3 Anti-Infective
8.3.1 Overview
8.3.2 Anti-Infective: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Endocrinology
8.4.1 Overview
8.4.2 Endocrinology: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Enteral Nutrition
8.5.1 Overview
8.5.2 Enteral Nutrition: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Pharmaceuticals
8.6.1 Overview
8.6.2 Specialty Pharmaceuticals: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hydration Therapy
8.7.1 Overview
8.7.2 Hydration Therapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Chemotherapy
8.8.1 Overview
8.8.2 Chemotherapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC HOME INFUSION THERAPY MARKET ANALYSIS AND FORECAST TO 2028 – BY ROUTE OF ADMINISTRATION
9.1 Overview
9.2 Asia Pacific Home Infusion Therapy Market, by Route of Administration, 2021 & 2028 (%)
9.3 Intramuscular
9.3.1 Overview
9.3.2 Intramuscular: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Subcutaneously
9.4.1 Overview
9.4.2 Subcutaneously: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Epidural
9.5.1 Overview
9.5.2 Epidural: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC HOME INFUSION THERAPY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Asia Pacific: Home Infusion Therapy Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.1.3.1 China: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.1.4 China: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 China Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.2 Japan: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.2.3.1 Japan: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.2.4 Japan: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 Japan: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.3 India: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.3.3.1 India: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.3.4 India: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 India: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.4 South Korea: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.4.3.1 South Korea: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.4.4 South Korea: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.4.5 South Korea: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.5 Australia: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.5.3.1 Australia: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.5.4 Australia: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.5.5 Australia: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
11. HOME INFUSION THERAPY MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Home Infusion Therapy Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 B. Braun Melsungen AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Baxter International Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Nipro Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Becton Dickinson and Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ICU Medical Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 JMS Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ETerumo Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Home Infusion Therapy Market – by Product
1.3.2 Asia Pacific Home Infusion Therapy Market – by Application
1.3.3 Asia Pacific Home Infusion Therapy Market – by Route of Administration
1.3.4 Asia Pacific Home Infusion Therapy Market – by Country
2. ASIA PACIFIC HOME INFUSION THERAPY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC HOME INFUSION THERAPY MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.2.1 Expert’s Opinion
5. ASIA PACIFIC HOME INFUSION THERAPY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Incidences of Chronic Disorders Coupled with Rising Geriatric Population
5.1.2 Reduction in Duration of Hospital Stays and Cost of Care
5.2 Market Restraints
5.2.1 Recalls of Infusion Pumps and Safety Concerns Associated with Home Infusion
5.3 Market Opportunities
5.3.1 Increasing Healthcare Potential of Developing Economies and Rising Prevalence of Healthcare-Associated Infections
5.4 Future Trends
5.4.1 Addressing Unmet Needs of Patients Suffering from Oncological and Hematological Conditions
5.5 Impact Analysis
6. HOME INFUSION THERAPY MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7. ASIA PACIFIC HOME INFUSION THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT
7.1 Overview
7.2 Asia Pacific Home Infusion Therapy Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Infusion Pumps
7.3.1 Overview
7.3.2 Infusion Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Insulin Pumps
7.3.3.1 Overview
7.3.3.2 Insulin Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Elastomeric Pumps
7.3.4.1 Overview
7.3.4.2 Elastomeric Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Syringe Pumps
7.3.5.1 Overview
7.3.5.2 Syringe Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intravenous Sets
7.4.1 Overview
7.4.2 Intravenous Sets: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 IV Cannulas
7.5.1 Overview
7.5.2 IV Cannulas: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Needleless Connectors
7.6.1 Overview
7.6.2 Needleless Connectors: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC HOME INFUSION THERAPY MARKET ANALYSIS AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 Asia Pacific Home Infusion Therapy Market, by Application 2021 & 2028 (%)
8.3 Anti-Infective
8.3.1 Overview
8.3.2 Anti-Infective: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Endocrinology
8.4.1 Overview
8.4.2 Endocrinology: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Enteral Nutrition
8.5.1 Overview
8.5.2 Enteral Nutrition: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Pharmaceuticals
8.6.1 Overview
8.6.2 Specialty Pharmaceuticals: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hydration Therapy
8.7.1 Overview
8.7.2 Hydration Therapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Chemotherapy
8.8.1 Overview
8.8.2 Chemotherapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC HOME INFUSION THERAPY MARKET ANALYSIS AND FORECAST TO 2028 – BY ROUTE OF ADMINISTRATION
9.1 Overview
9.2 Asia Pacific Home Infusion Therapy Market, by Route of Administration, 2021 & 2028 (%)
9.3 Intramuscular
9.3.1 Overview
9.3.2 Intramuscular: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Subcutaneously
9.4.1 Overview
9.4.2 Subcutaneously: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Epidural
9.5.1 Overview
9.5.2 Epidural: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC HOME INFUSION THERAPY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Asia Pacific: Home Infusion Therapy Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.1.3.1 China: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.1.4 China: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 China Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.2 Japan: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.2.3.1 Japan: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.2.4 Japan: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 Japan: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.3 India: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.3.3.1 India: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.3.4 India: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 India: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.4 South Korea: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.4.3.1 South Korea: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.4.4 South Korea: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.4.5 South Korea: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.5 Australia: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.5.3.1 Australia: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.5.4 Australia: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.5.5 Australia: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Home Infusion Therapy Market, by Product, 2019–2028 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Home Infusion Therapy Market, by Infusion Pumps, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Home Infusion Therapy Market, by Application, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Home Infusion Therapy Market, by Route of Administration, 2019–2028 (US$ Million)
11. HOME INFUSION THERAPY MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Home Infusion Therapy Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 B. Braun Melsungen AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Baxter International Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Nipro Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Becton Dickinson and Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ICU Medical Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 JMS Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ETerumo Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. China Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 3. China Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. China Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 9. India Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. India Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 11. India Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. India Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 15. South Korea Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 19. Australia Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Asia Pacific Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Asia Pacific Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Asia Pacific Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Asia Pacific Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Inorganic Growth Strategies in the Home Infusion Therapy Market
Table 26. Recent Organic Growth Strategies in the Home Infusion Therapy Market
Table 27. Glossary of Terms
Table 1. China Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 3. China Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. China Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 9. India Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. India Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 11. India Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. India Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 15. South Korea Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 19. Australia Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Asia Pacific Home Infusion Therapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Asia Pacific Home Infusion Therapy Market, by Infusion Pumps – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Asia Pacific Home Infusion Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Asia Pacific Home Infusion Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Inorganic Growth Strategies in the Home Infusion Therapy Market
Table 26. Recent Organic Growth Strategies in the Home Infusion Therapy Market
Table 27. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Home Infusion Therapy Market Segmentation
Figure 2. Asia Pacific Home Infusion Therapy Market, by Country
Figure 3. Asia Pacific Home Infusion Therapy Market Overview
Figure 4. Infusion Pumps Segment Held Largest Share of Product Segment in Asia Pacific Home Infusion Therapy Market
Figure 5. India is Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Home Infusion Therapy Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Asia Pacific Home Infusion Therapy Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Infusion Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Insulin Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Elastomeric Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Syringe Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Intravenous Sets: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IV Cannulas: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Needleless Connectors: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Asia Pacific Home Infusion Therapy Market, by Application 2021 & 2028 (%)
Figure 20. Anti-Infective: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Enteral Nutrition: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Specialty Pharmaceuticals: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hydration Therapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Chemotherapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Asia Pacific Home Infusion Therapy Market, by Route of Administration, 2021 & 2028 (%)
Figure 28. Intramuscular: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Subcutaneously: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Epidural: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Asia Pacific: Home Infusion Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 32. China: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Japan: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. India: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South Korea: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Australia: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Growth Strategies in the Home Infusion Therapy Market
Figure 1. Asia Pacific Home Infusion Therapy Market Segmentation
Figure 2. Asia Pacific Home Infusion Therapy Market, by Country
Figure 3. Asia Pacific Home Infusion Therapy Market Overview
Figure 4. Infusion Pumps Segment Held Largest Share of Product Segment in Asia Pacific Home Infusion Therapy Market
Figure 5. India is Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Home Infusion Therapy Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Asia Pacific Home Infusion Therapy Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Infusion Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Insulin Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Elastomeric Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Syringe Pumps: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Intravenous Sets: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IV Cannulas: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Needleless Connectors: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Asia Pacific Home Infusion Therapy Market, by Application 2021 & 2028 (%)
Figure 20. Anti-Infective: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Enteral Nutrition: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Specialty Pharmaceuticals: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hydration Therapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Chemotherapy: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Asia Pacific Home Infusion Therapy Market, by Route of Administration, 2021 & 2028 (%)
Figure 28. Intramuscular: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Subcutaneously: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Epidural: Asia Pacific Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Asia Pacific: Home Infusion Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 32. China: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Japan: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. India: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South Korea: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Australia: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Asia Pacific: Home Infusion Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Growth Strategies in the Home Infusion Therapy Market
